Purple Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 18-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.60 Cr
as on 18-12-2024
- Revenue 256923.08%
(FY 2023)
- Profit -231.27%
(FY 2023)
- Ebitda -242.74%
(FY 2023)
- Net Worth 1219.99%
(FY 2023)
- Total Assets 212.07%
(FY 2023)
About Purple Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹6.60 Cr.
Pravinbhai Sorathia, Heena Pethani, and Vishvas Ranpariya serve as directors at the Company.
- CIN/LLPIN
U73200GJ2020PTC116260
- Company No.
116260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Purple Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishvas Ranpariya  | Managing Director | 07-Sep-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pravinbhai Sorathia | Director | 25-Jan-2021 | Current |
| Heena Pethani | Director | 07-Sep-2020 | Current |
Financial Performance of Purple Laboratories.
Purple Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 256923.08% increase. The company also saw a substantial fall in profitability, with a 231.27% decrease in profit. The company's net worth Soared by an impressive increase of 1219.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purple Laboratories?
In 2023, Purple Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 May 2022 | ₹6.60 Cr | Open |
How Many Employees Work at Purple Laboratories?
Purple Laboratories has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purple Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purple Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
